ZRO — Biosenta Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$4.62m
- CA$9.98m
- CA$0.00m
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.53 | -0.762 | -2.04 | -1.46 | -6.3 |
Amortisation | |||||
Non-Cash Items | 0.008 | 0.021 | 0.988 | 0.143 | 4.96 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.195 | 0.421 | 0.381 | 0.811 | 0.79 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -0.327 | -0.32 | -0.672 | -0.504 | -0.551 |
Capital Expenditures | — | — | — | — | -0.016 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | — | — | — | — | -0.016 |
Financing Cash Flow Items | 0.325 | 0.282 | 0.327 | 0.477 | 0.267 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.325 | 0.354 | 0.74 | 0.42 | 0.545 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.002 | 0.035 | 0.068 | -0.085 | -0.021 |